Remove Diagnostic Remove Medicare Remove Radiopharmaceuticals
article thumbnail

Medicare to boost payment for certain diagnostic imaging agents

Radiology Business

CMS is moving forward with a proposal to issue separate reimbursement for radiopharmaceuticals—a change long lobbied for by the imaging industry.

article thumbnail

CMS proposes new coverage for PET imaging agents

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GE HealthCare to launch Flyrcado injection in U.S.

AuntMinnie

Flyrcado delivers higher diagnostic efficacy compared with standard SPECT MPI,GE said. GE HealthCare's launch coincides with the receipt of pass-through status by the Centers for Medicare & Medicaid Services (CMS), effectiveApril 1st. Food and Drug Administration (FDA) for the injection in 2024.Flyrcadois

article thumbnail

CMS Adjusts Nuclear Medicine Reimbursement Policy, Expanding Access to Life-Saving Scans

Imaging Technology

1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). However, under the previous reimbursement system, diagnostic radiopharmaceuticals were bundled as “supplies,” limiting access in several ways.

article thumbnail

New CMS plan adds Medicare coverage of PET imaging agents

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 130
article thumbnail

Nuclear cardiology could face cuts in 2025

AuntMinnie

Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. Ultimately, there are “many unknowns” to be explored in the next few months – implications regarding the unknown cost of new diagnostic radiopharmaceuticals, for instance – and the ASNC is in continuing talks with the CMS.

article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.